Versigent Plc · NYSE:VGNT
Versigent — Q3 2026 Earnings Presentation
24 slides from Versigent's earnings presentation, Nov 4, 2026
Slide 1: Q3 2026 Earnings
Q3 2026 Earnings November 4, 2026
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation, as well as other statements made by Versigent, contains forward-looking statements that reflect, when made, Versigent’s current views with respect to current events, certain investments and acquisitions, business plans and financial performance. Such for
Slide 3: Business Priorities
Business Priorities Unlocking value for shareholders as an independent company Further strengthen market leading position • Increase share by leveraging full-service capabilities and best-in-class operating model • Leverage scale and capabilities in Automotive and other high-value end markets Contin
Slide 4: Q3 2026 Highlights
Q3 2026 Highlights Delivering Results Through Strong Execution and Operational Discipline Amid Softer Industry Environment Strong Financial Performance Commercial Momentum • Net Sales +7% YoY • $2.1B Q3 bookings2 across new and existing customers o Adjusted Net Sales Growth1 +1% YoY • 55 launches ac
Slide 5: Q3 2026 Financial Results
Q3 2026 Financial Results Q3 2026 Earnings | 5
Slide 6: Q3 2026 Financial Highlights
Q3 2026 Financial Highlights $ millions, except per share amounts Q3 2026 Q3 2025 YoY Commentary • Reported net sales includes ~500 bps of commodity Net Sales +7% pass-throughs and ~100 bps of favorable FX $2,450 $2,286 Adjusted Net Sales Growth1 +1% • Delivered growth despite lower global automotiv
Slide 7: Q3 Net Sales
Q3 Net Sales Regional Net Sales $ millions +7% Americas +1% Adjusted Net Sales Growth1 Adjusted* $1,111M +6% YoY +1% YoY $112 $2,450 $20 Asia Pacific $21 $2,286 $11 Adjusted* $868M +18% YoY +9% YoY EMEA Adjusted* $471M (6)% YoY (8)% YoY Q3 2025 Volume Net Pricing FX Commodity Q3 2026 Impacts *Adjust
Slide 8: Q3 Adjusted EBITDA
Q3 Adjusted EBITDA1 $ millions % = Adjusted EBITDA1 Margin +11% $8 $3 $275 $21 $(7) $248 $2 10.8% 11.2% Q3 2025 Volume Net Pricing FX Commodity Net Q3 2026 Impacts Performance (1) Non-GAAP measure. Refer to Appendix for further details and reconciliation to most directly comparable U.S. GAAP measure
Slide 9: Q3 Free Cash Flow and Financial Position
Q3 Free Cash Flow1 and Financial Position Free Cash Flow $ millions Q3 2026 Q3 2025 YoY Adjusted EBITDA1 $275 $248 $27 Financial Position Capital expenditures (55) (44) (11) Strong liquidity and leverage profile Separation costs (11) (7) (4) as of Sep 30 ’26: Restructuring payments (11) (13) 2 • $1.
Slide 10: Updated FY 2026 Financial Guidance
Updated FY 2026 Financial Guidance Current FY 2026 Previous FY 2026 $ millions (Aug 4 ‘26) Net Sales $9,500 – $9,600 $9,400 – $9,600 Raised midpoint and tightened Adjusted Net Sales Growth %1,2 +2% +2% Net Sales guidance range on higher commodity pass-throughs Adjusted EBITDA3 $970 – $1,010 $950 – $
Slide 11: Capital Allocation
Capital Allocation Capital Allocation Framework Free Cash Flow1 Capital Expenditures • Target ~3% of annual net sales ~$1B Quarterly Dividend2 • $0.13 per share dividend declared on Nov 3 ‘26 o Record date: Dec 4 ‘26; Payment date: Dec 17 ‘26 Cumulative FCF Generation 2026E to 2028E Share Repurchase
Slide 12: Summary
Summary Building Momentum, Advancing Strategic Priorities Executed a significant number of program launches while delivering solid third quarter results Demonstrated strength and resilience of our business model amid lower global automotive production and volatile macroeconomic environment Guidance
Slide 13: Appendix
Appendix Q3 2026 Earnings | 13
Slide 14: Supplemental Information
Supplemental Information Non-GAAP Financial Measures (unaudited) In addition to its reported results calculated in accordance with U.S. GAAP, the Company has included in this presentation Adjusted Net Sales Growth, Adjusted EBITDA, Adjusted Net Income, Adjusted Diluted EPS and Adjusted ETR, performa
Slide 15: YTD Results
YTD Results $ millions, except per share amounts YTD 2026 YTD 2025 YoY Net Sales $7,106 $6,516 +9% Adjusted Net Sales Growth1 +3% Adjusted EBITDA1 $750 $664 +13% Margin 10.6% 10.2% +40 bps Adjusted Diluted EPS1, 2 $5.90 $5.30 +11% Free Cash Flow1 $247 $290 (15)% (1) Non-GAAP measure. Refer to Supple
Slide 16: YTD Net Sales
YTD Net Sales Regional Net Sales $ millions +9% Americas +3% Adjusted Net Sales Growth1 Adjusted* $264 $7,106 $3,170M +9% YoY +4% YoY $126 $191 $9 Asia Pacific $6,516 Adjusted* $2,432M +19% YoY +12% YoY EMEA Adjusted* $1,504M (4)% YoY (10)% YoY YTD 2025 Volume Net Pricing FX Commodity YTD 2026 Impac
Slide 17: YTD Adjusted EBITDA
YTD Adjusted EBITDA1 $ millions % = Adjusted EBITDA1 Margin +13% $75 $750 $46 $9 $3 $664 $(47) 10.2% 10.6% YTD 2025 Volume Net Pricing FX Commodity Net YTD 2026 Impacts Performance (1) Non-GAAP measure. Refer to Supplemental Information included herein for further details and reconciliation to most
Slide 18: YTD Free Cash Flow
YTD Free Cash Flow1 $ millions YTD 2026 YTD 2025 YoY Adjusted EBITDA1 $750 $664 $86 Capital expenditures (172) (123) (49) Separation costs (59) (14) (45) Restructuring payments (48) (41) (7) Tax payments (74) (72) (2) Interest payments (18) (2) (16) Working capital & other (132) (122) (10) Free Cash
Slide 19: Reconciliation of Net Sales to Adjusted Net Sales Growth
Reconciliation of Net Sales to Adjusted Net Sales Growth Q3 2026 YTD 2026 Reported net sales YoY % change 7% 9% Less: impact of foreign currency movements (1)% (2)% Global Less: impact of commodity movements (5)% (4)% Adjusted Net Sales Growth 1% 3% Reported net sales YoY % change 6% 9% Americas Les
Slide 20: Reconciliation of Net Income to EBITDA and Adjusted EBITDA and Net Leverage Ratio
Reconciliation of Net Income Attributable to Versigent to EBITDA and Adjusted EBITDA and Net Leverage Ratio TTM Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 YTD 2026 YTD 2025 $ millions Sep 2026 Net income attributable to Versigent 109 217 78 118 102 515 298 311 Interest expense1 ̶ ̶ 5 36 36 77 77 3 Inco
Slide 21: Reconciliation to Adjusted Net Income and Adjusted Diluted EPS
Reconciliation of Net Income Attributable to Versigent to Adjusted Net Income and Adjusted Diluted EPS $ millions, except per share amounts Q3 2026 Q3 2025 YTD 2026 YTD 2025 Net income attributable to Versigent 102 109 298 311 Adjusting items: Amortization ̶ ̶ 1 1 Restructuring 22 21 68 62 Separatio
Slide 22: Reconciliation of Operating Cash Flow to Free Cash Flow
Reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow $ millions Q3 2026 Q3 2025 YTD 2026 YTD 2025 Net cash provided by operating activities 225 223 419 413 Capital expenditures (55) (44) (172) (123) Free Cash Flow 170 179 247 290 Q3 2026 Earnings | 22
Slide 23: Reconciliation of Effective Tax Rate to Adjusted ETR
Reconciliation of Effective Tax Rate to Adjusted ETR $ millions Q3 2026 Q3 2025 YTD 2026 YTD 2025 Income before income taxes and equity income 147 164 372 414 Plus: impact of adjusting items1 43 29 149 84 Adjusted Income Before Income Taxes and Equity Income 190 193 521 498 Income tax expense (35) (
Slide 24: Versigent
“) Versigent